About Enhancer

Enhancer ID: E_01_0650
Species: human
Position : chr5:88713851-88715851
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Rett (? like) syndrome or nonsyndromic intellectual disability in china
Pubmed ID:  30376817
Enhancer experiment: Seq
Enhancer experiment description: MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT

About TF

TF name : MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2)
TF experiment: Seq
TF experiment description: MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT

About Function

Enhancer function : MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
MEF2C CDO in myogenesis reactome 29
MEF2C Circadian Clock reactome 49
MEF2C ErbB1 downstream signaling pid 105
MEF2C ERK/MAPK targets reactome 17
MEF2C Notch netpath 76
MEF2C Oxidative stress response panther 23
MEF2C p38 MAPK pathway panther 31
MEF2C Regulation of nuclear SMAD2/3 signaling pid 82
MEF2C Regulation of retinoblastoma protein pid 67
MEF2C Signaling events mediated by HDAC Class II pid 58
MEF2C Signaling mediated by p38-alpha and p38-beta pid 35
MEF2C TGF_beta_Receptor netpath 220
MEF2C Transcriptional activation of mitochondrial biogenesis reactome 43
MEF2C Trk receptor signaling mediated by the MAPK pathway pid 34
MEF2C MAPK signaling pathway kegg 264
MEF2C Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
MEF2C Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 wikipathways 153
MEF2C Hs_Heart_Development_WP1591_90186 wikipathways 28
MEF2C Hs_Oxidation_by_Cytochrome_P450_WP43_84102 wikipathways 14
MEF2C Hs_TGF-beta_Signaling_Pathway_WP366_90028 wikipathways 67

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs